Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 Read more about Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025
Arcturus Therapeutics to Attend Upcoming Investor Conferences Read more about Arcturus Therapeutics to Attend Upcoming Investor Conferences
Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program Read more about Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program
Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency Read more about Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency
Arcturus Therapeutics to Attend Upcoming Investor Conferences Read more about Arcturus Therapeutics to Attend Upcoming Investor Conferences
Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress Read more about Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025 Read more about Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1 Read more about Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2024 Financial Update and Pipeline Progress Read more about Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2024 Financial Update and Pipeline Progress
Arcturus Therapeutics to Present at Leerink’s Global Healthcare Conference 2025 Read more about Arcturus Therapeutics to Present at Leerink’s Global Healthcare Conference 2025